Resources for Sponsors Expanding Immuno-oncology Pipeline Assets
Understand the role of a CRO across all phases of immuno-oncology drug development
Steven Anderson PhD, Chief Scientific Officer


MarketPlace Video

Case Study: Flexibility for a Successful Partnership
Rapidly establishing relevant models for preclinical oncology success

Case Study: End-to-end Drug and Diagnostic Development
Support in immuno-oncology from preclinical design to approved product launch